Bos I - Search Results

1

In vitro interaction of C1-inhibitor with thrombin.

Cugno M, Bos I, Lubbers Y, Hack CE, Agostoni A. Cugno M, et al. Among authors: bos i. Blood Coagul Fibrinolysis. 2001 Jun;12(4):253-60. doi: 10.1097/00001721-200106000-00005. Blood Coagul Fibrinolysis. 2001. PMID: 11460008

2

Structural and functional aspects of C1-inhibitor.

Bos IG, Hack CE, Abrahams JP. Bos IG, et al. Immunobiology. 2002 Sep;205(4-5):518-33. doi: 10.1078/0171-2985-00151. Immunobiology. 2002. PMID: 12396012 Review.

3

The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant.

Bos IG, Lubbers YT, Roem D, Abrahams JP, Hack CE, Eldering E. Bos IG, et al. J Biol Chem. 2003 Aug 8;278(32):29463-70. doi: 10.1074/jbc.M302977200. Epub 2003 May 27. J Biol Chem. 2003. PMID: 12773530 Free article.

4

Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitor.

Bos IG, Lubbers YT, Eldering E, Abrahams JP, Hack CE. Bos IG, et al. Biochim Biophys Acta. 2004 Jun 1;1699(1-2):139-44. doi: 10.1016/j.bbapap.2004.02.006. Biochim Biophys Acta. 2004. PMID: 15158721

5

The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.

Bos IG, van Mierlo GJ, Bleeker WK, Rigter GM, te Velthuis H, Dickneite G, Hack CE. Bos IG, et al. Int Immunopharmacol. 2001 Aug;1(8):1583-95. doi: 10.1016/s1567-5769(01)00073-x. Int Immunopharmacol. 2001. PMID: 11515821

6

Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor.

Bos IG, de Bruin EC, Karuntu YA, Modderman PW, Eldering E, Hack CE. Bos IG, et al. Biochim Biophys Acta. 2003 May 30;1648(1-2):75-83. doi: 10.1016/s1570-9639(03)00107-9. Biochim Biophys Acta. 2003. PMID: 12758149

7

Role of complement in graft rejection after organ transplantation.

Bos IG, Ten Berge IJ, Hack CE. Bos IG, et al. Transfus Med Rev. 2002 Jul;16(3):251-64. doi: 10.1053/tmrv.2002.33460. Transfus Med Rev. 2002. PMID: 12075562 Review.

8

Pharmaceutical proteins from methylotrophic yeasts.

de Bruin EC, Duitman EH, de Boer AL, Veenhuis M, Bos IG, Hack CE. de Bruin EC, et al. Methods Mol Biol. 2005;308:65-76. doi: 10.1385/1-59259-922-2:065. Methods Mol Biol. 2005. PMID: 16082026 No abstract available.

9

Longitudinal assessment of health-related quality of life after SARS-CoV-2 infection and the associations with clinical and social characteristics in a general practice population.

van den Hoek R, Hek K, Bos I, Hak E, van Dijk L. van den Hoek R, et al. Among authors: bos i. Health Qual Life Outcomes. 2024 Oct 9;22(1):86. doi: 10.1186/s12955-024-02301-7. Health Qual Life Outcomes. 2024. PMID: 39385291 Free PMC article.

10

Care needs of patients with the post-COVID syndrome in Dutch general practice: an interview study among patients and general practitioners.

Rijpkema C, Knottnerus BJ, van den Hoek R, Bosman L, van Dijk L, Verheij RA, Bos I. Rijpkema C, et al. Among authors: bos i. BMC Prim Care. 2024 Sep 28;25(1):355. doi: 10.1186/s12875-024-02597-w. BMC Prim Care. 2024. PMID: 39342189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters